Periconception PrEP for HIV-exposed Ugandan Women

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

April 1, 2019

Study Completion Date

December 30, 2020

Conditions
HIV Prevention
Interventions
BEHAVIORAL

Safer conception counseling inclusive of periconception PrEP

Observational evaluation of factors associated with uptake of and adherence to daily, oral TDF/FTC PrEP and other safer conception methods (including: CHCT, ART for the infected partner, and uptake of contraception for those who decide not to conceive during follow-up) over 9 month. Maximum 19 month follow-up period (through pregnancy outcome).

Trial Locations (1)

Unknown

Mbarara University of Science and Technology, Mbarara

All Listed Sponsors
collaborator

Mbarara University of Science and Technology

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03832530 - Periconception PrEP for HIV-exposed Ugandan Women | Biotech Hunter | Biotech Hunter